Page last updated: 2024-11-03

primaquine and Injuries

primaquine has been researched along with Injuries in 1 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Injuries: Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used.

Research Excerpts

ExcerptRelevanceReference
"Of 751 trauma patients with available post-admission data, 42% received primary chemoprophylaxis for four weeks, 33% received primaquine for 14 days, and 17% received both."1.40Compliance with antimalarial chemoprophylaxis recommendations for wounded United States military personnel admitted to a military treatment facility. ( Aggarwal, D; Carson, ML; Li, P; Lloyd, BA; Murray, CK; Rini, EA; Shaikh, F; Tribble, DR; Warkentien, TE; Weintrob, AC, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rini, EA1
Weintrob, AC1
Tribble, DR1
Lloyd, BA1
Warkentien, TE1
Shaikh, F1
Li, P1
Aggarwal, D1
Carson, ML1
Murray, CK1

Other Studies

1 other study available for primaquine and Injuries

ArticleYear
Compliance with antimalarial chemoprophylaxis recommendations for wounded United States military personnel admitted to a military treatment facility.
    The American journal of tropical medicine and hygiene, 2014, Volume: 90, Issue:6

    Topics: Adult; Afghanistan; Antimalarials; Doxycycline; Female; Hospitalization; Humans; Malaria; Male; Mili

2014